JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on March 2, 2005; DOI: 10.1124/jpet.104.082420


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.104.082420v1
313/3/1239    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tawfik, V. L.
Right arrow Articles by DeLeo, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tawfik, V. L.
Right arrow Articles by DeLeo, J. A.


Received for publication January 10, 2005.
Revised February 26, 2005.
Accepted for publication February 28, 2005.

Transcriptional and Translational Regulation of Glial Activation by Morphine in a Rodent Model of Neuropathic Pain

Vivianne L. Tawfik 1, Michael L. Lacroix-Fralish 1, Nancy Nutile-McMenemy 1, Joyce A. DeLeo 2*

1 Dartmouth Medical School 2 Dartmouth Hitchcock Medical Center

* Address correspondence to: E-mail: joyce.a.deleo{at}dartmouth.edu

Abstract

Glial cells function in maintenance of homeostasis as well as in pathophysiology. In this study, we determined the time course of spinal glial cell activation during the development of morphine analgesic tolerance in an L5 spinal nerve transection rodent model of neuropathic pain. We also sought to assess whether the method of morphine administration affected neuroimmune activation at the levels of transcription and translation. Rats received L5 spinal nerve transection or no surgery on day 0. On day 6 post-transection, osmotic mini-pumps were implanted to deliver saline or morphine subcutaneously (1 or 10 mg/kg) or intrathecally (5 or 20 nmol/hr). Mechanical allodynia developed immediately after spinal nerve transection; this hypersensitivity was reversed with both low and high dose morphine by either route. Tolerance to anti-allodynia developed after 3 days of intrathecal morphine and after 6 days of subcutaneous morphine, indicating hastened tolerance following intrathecal delivery. Analysis of mRNA revealed that subcutaneous morphine treatment did not lead to increases in glial activation markers. In contrast, intrathecal morphine caused a biphasic alteration in GFAP and ITGAM mRNA. Protein levels for GFAP were elevated after both subcutaneous and intrathecal administration of morphine, however induction was further enhanced in the latter group. Here we show for the first time that there is differential recruitment of transcriptional and translational mechanisms of glial activation by systemic and intrathecal morphine. Further, we suggest that enhanced neuroimmune activation after intrathecal dosing contributes to the hastened development of analgesic tolerance seen in these animals.


Key words: Astrocytes, Cytokines, Gene regulation, Microglia, Neuroimmune activation, Spinal Glia





Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics.